Avantor® to Boost Global Production of Single­-Use Technologies and Address Growing Biopharma Demand

Share this article
Share this article
RADNOR, Pa., April 26, 2021 /PRNewswire/ -- Avantor Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies and applied materials industries, today announced that it will increase global capacity for high-quality single-use technologies used in the production of biologics and vaccines.
In the U.S. and Europe, the Company will increase its single-use manufacturing footprint by 30% and double its cleanroom space. The investment will support growing customer demand for monoclonal antibodies (mAbs), novel cell and gene therapies for oncology and other diseases, as well as vaccines, including those for COVID-19.

Related Keywords

Netherlands ,Morrisville ,North Carolina ,United States ,Hillegom ,Zuid Holland ,Massachusetts ,Robert Donohoe ,Linkedin ,Twitter ,Corporate Communications ,Facebook ,Ger Brophy ,Executive Vice President ,Biopharma Production ,Media Contact ,நெதர்லாந்து ,மோரிஸ்வில்லே ,வடக்கு கரோலினா ,ஒன்றுபட்டது மாநிலங்களில் ,மாசசூசெட்ஸ் ,ராபர்ட் தொனொோே ,சென்டர் ,ட்விட்டர் ,பெருநிறுவன தகவல்தொடர்புகள் ,முகநூல் ,ஜெர் கோப்பை ,நிர்வாகி துணை ப்ரெஸிடெஂட் ,மீடியா தொடர்பு ,